NCT05423366

Brief Summary

There is no scientific study in the literature regarding the use of different extracorporeal shock wave therapies (ESWT) in the treatment of patellar tendinopathy. In this study, we aim to investigate both the effectiveness of ESWT and which type of ESWT can be more effective in the treatment of patellar tendinopathy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 21, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

September 16, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2022

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2022

Completed
Last Updated

February 1, 2023

Status Verified

January 1, 2023

Enrollment Period

2 months

First QC Date

June 14, 2022

Last Update Submit

January 31, 2023

Conditions

Outcome Measures

Primary Outcomes (8)

  • Visual Analogue Scale (VAS)

    patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse

    at baseline.

  • Visual Analogue Scale (VAS)

    patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse

    3 weeks after baseline.

  • Visual Analogue Scale (VAS)

    patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse

    7 weeks after baseline.

  • Visual Analogue Scale (VAS)

    patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse

    15 weeks after baseline.

  • Victorian Institute of Sports Assessment-Patella (VISA-P)

    The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy.

    at baseline.

  • Victorian Institute of Sports Assessment-Patella (VISA-P)

    The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy.

    3 weeks after baseline.

  • Victorian Institute of Sports Assessment-Patella (VISA-P)

    The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy.

    7 weeks after baseline.

  • Victorian Institute of Sports Assessment-Patella (VISA-P)

    The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy.

    15 weeks after baseline.

Study Arms (3)

Large-Focused Extracorporeal Shock Wave Therapy

ACTIVE COMPARATOR
Device: Extracorporeal Shock Wave Therapy (ESWT)

Controlled-Unfocused (Radial) Extracorporeal Shock Wave Therapy

ACTIVE COMPARATOR
Device: Extracorporeal Shock Wave Therapy (ESWT)

Sham Extracorporeal Shock Wave Therapy

SHAM COMPARATOR
Device: Extracorporeal Shock Wave Therapy (ESWT)

Interventions

The ESWT device is product of Elettronica Pagani, Italy.

Controlled-Unfocused (Radial) Extracorporeal Shock Wave TherapyLarge-Focused Extracorporeal Shock Wave TherapySham Extracorporeal Shock Wave Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Engaging in active sports, being 18 years or older, history of activity-related knee pain in the patellar tendon or patellar insertion, symptoms lasting longer than 8 weeks (non-acute), VISA-P score less than 80 before treatment, pain during knee loading on tendon or tendon it remains isolated in the limited part of the bone junction and does not spread to the entire patellar region (to differentiate patellar tendinopathy and patellofemoral pain).

You may not qualify if:

  • Being under the age of 18, acute knee or acute patellar tendon injury, chronic inflammatory joint diseases (rheumatoid arthritis, etc.), using immunosuppressive or corticosteroid medication in the last 6 months, previous knee surgery (in the anterior cruciate ligament or patellar tendon), knee in the last 1 month local (corticosteroid) injection, contraindications for ESWT treatment (eg pregnancy, malignancy, coagulopathy), previous ESWT treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yuzuncu Yil University

Van, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Extracorporeal Shockwave Therapy

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Volkan Şah

    Yüzüncü Yıl Üniversitesi Tıp Fakültesi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 14, 2022

First Posted

June 21, 2022

Study Start

September 16, 2022

Primary Completion

November 28, 2022

Study Completion

December 19, 2022

Last Updated

February 1, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations